CLL Furman et al. (2014) reported on a study of patients with recurring chronic lymphocytic leukemia (CLL). The study was randomized, double-blind, and placebo-controlled. After 12 months, 101 of the 110 patients assigned to the combination treatment of idelalisib (idel) with rituximab (rit) were still alive, and 88 of the 110 patients assigned to placebo with rit were still alive. Perform a hypothesis test to test whether those who take idel have a better chance of surviving than those taking the placebo. Use a level of significance of 0.05. Can we conclude that idel causes an increased chance of survival? See page 406 for guidance.
Answer to relevant QuestionsA vaccine to prevent severe rotavirus gastroenteritis (diarrhea) was given to African children within the first year of life as part of a drug study. The study reported that of the 3298 children randomly assigned the ...In a 1997 study, people were observed for about 10 seconds in public places, such as malls and restaurants, to determine whether they smiled during the randomly chosen 10-second interval. The table shows the results for ...Mary was tested to see whether she could tell peppermint gum from spearmint gum by smell alone. She got 12 right out of 20, and the p-value was 0.186. Explain what is wrong with the following conclusion, and write a correct ...Some sources report that the weights of full-term newborn babies have a mean of 7 pounds and a standard deviation of 0.6 pound and are Normally distributed. a. What is the probability that one newborn baby will have a weight ...A statistics instructor randomly selected four bags of oranges; each bag labeled 10 pounds, and weighed the bags. They weighed 10.2, 10.5, 10.3, and 10.3 pounds. Assume that the distribution of weights is Normal. Find a 95% ...
Post your question